Dermata Therapeutics Announces August 25 Launch Of Tome Foundational Treatment At $178 For Four Weekly Treatments, Its First Commercial Product
Share
Why It Matters
Dermata Therapeutics is selling its first medicine to customers, starting August 25, for $178 per patient. When a company launches its first real product, watch to see if people actually want to buy it—that tells you if the company's big idea actually works.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.